Global Chronic Obstructive Pulmonary Disease Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
Jan, 2019
|
Report ID: 41227
|
118
|
Pharmaceuticals and Healthcare
Chronic obstructive pulmonary disease (COPD) is a type of obstructive lung disease characterized by long-term breathing problems and poor airflow The main symptoms include shortness of breath and cough with sputum production. COPD is a progressive disease, meaning it typically worsens over time. Eventually everyday activities, such as walking or getting dressed, become difficult .Chronic bronchitis and emphysema are older terms used for different types of COPD.
Scope of the Report:
This report studies the Chronic Obstructive Pulmonary Disease market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Chronic Obstructive Pulmonary Disease market by product type and applications/end industries.
Globally the market for COPD is increasing rapidly. The major factor that derives the growth of COPD is the increasing growth in smoking in adults. Furthermore increasing pollution in the environment and increasing asthma patients are increasing the growth of COPD market.
The global Chronic Obstructive Pulmonary Disease market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Chronic Obstructive Pulmonary Disease.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
AstraZeneca
GSK
MSD
Sunovion
Novartis
Roche Group
Pfizer
Jubilant Pharma Limited
Almirall
Horizon Pharma
Boehringer Ingelheim
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Bronchodilators
Glucocorticoids
Other
Market Segment by Applications, can be divided into
Prevention
Diagnostic
Treatment
Scope of the Report:
This report studies the Chronic Obstructive Pulmonary Disease market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Chronic Obstructive Pulmonary Disease market by product type and applications/end industries.
Globally the market for COPD is increasing rapidly. The major factor that derives the growth of COPD is the increasing growth in smoking in adults. Furthermore increasing pollution in the environment and increasing asthma patients are increasing the growth of COPD market.
The global Chronic Obstructive Pulmonary Disease market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Chronic Obstructive Pulmonary Disease.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
AstraZeneca
GSK
MSD
Sunovion
Novartis
Roche Group
Pfizer
Jubilant Pharma Limited
Almirall
Horizon Pharma
Boehringer Ingelheim
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Bronchodilators
Glucocorticoids
Other
Market Segment by Applications, can be divided into
Prevention
Diagnostic
Treatment
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Chronic Obstructive Pulmonary Disease Market Overview
1.1 Product Overview and Scope of Chronic Obstructive Pulmonary Disease
1.2 Classification of Chronic Obstructive Pulmonary Disease by Types
1.2.1 Global Chronic Obstructive Pulmonary Disease Revenue Comparison by Types (2017-2023)
1.2.2 Global Chronic Obstructive Pulmonary Disease Revenue Market Share by Types in 2017
1.2.3 Bronchodilators
1.2.4 Glucocorticoids
1.2.5 Other
1.3 Global Chronic Obstructive Pulmonary Disease Market by Application
1.3.1 Global Chronic Obstructive Pulmonary Disease Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Prevention
1.3.3 Diagnostic
1.3.4 Treatment
1.4 Global Chronic Obstructive Pulmonary Disease Market by Regions
1.4.1 Global Chronic Obstructive Pulmonary Disease Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Chronic Obstructive Pulmonary Disease Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Chronic Obstructive Pulmonary Disease Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Chronic Obstructive Pulmonary Disease Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Chronic Obstructive Pulmonary Disease Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Chronic Obstructive Pulmonary Disease Status and Prospect (2013-2023)
1.5 Global Market Size of Chronic Obstructive Pulmonary Disease (2013-2023)
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 Business Overview
2.1.2 Chronic Obstructive Pulmonary Disease Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 AstraZeneca Chronic Obstructive Pulmonary Disease Revenue, Gross Margin and Market Share (2016-2017)
2.2 GSK
2.2.1 Business Overview
2.2.2 Chronic Obstructive Pulmonary Disease Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 GSK Chronic Obstructive Pulmonary Disease Revenue, Gross Margin and Market Share (2016-2017)
2.3 MSD
2.3.1 Business Overview
2.3.2 Chronic Obstructive Pulmonary Disease Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 MSD Chronic Obstructive Pulmonary Disease Revenue, Gross Margin and Market Share (2016-2017)
2.4 Sunovion
2.4.1 Business Overview
2.4.2 Chronic Obstructive Pulmonary Disease Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sunovion Chronic Obstructive Pulmonary Disease Revenue, Gross Margin and Market Share (2016-2017)
2.5 Novartis
2.5.1 Business Overview
2.5.2 Chronic Obstructive Pulmonary Disease Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Novartis Chronic Obstructive Pulmonary Disease Revenue, Gross Margin and Market Share (2016-2017)
2.6 Roche Group
2.6.1 Business Overview
2.6.2 Chronic Obstructive Pulmonary Disease Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Roche Group Chronic Obstructive Pulmonary Disease Revenue, Gross Margin and Market Share (2016-2017)
2.7 Pfizer
2.7.1 Business Overview
2.7.2 Chronic Obstructive Pulmonary Disease Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Pfizer Chronic Obstructive Pulmonary Disease Revenue, Gross Margin and Market Share (2016-2017)
2.8 Jubilant Pharma Limited
2.8.1 Business Overview
2.8.2 Chronic Obstructive Pulmonary Disease Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Jubilant Pharma Limited Chronic Obstructive Pulmonary Disease Revenue, Gross Margin and Market Share (2016-2017)
2.9 Almirall
2.9.1 Business Overview
2.9.2 Chronic Obstructive Pulmonary Disease Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Almirall Chronic Obstructive Pulmonary Disease Revenue, Gross Margin and Market Share (2016-2017)
2.10 Horizon Pharma
2.10.1 Business Overview
2.10.2 Chronic Obstructive Pulmonary Disease Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Horizon Pharma Chronic Obstructive Pulmonary Disease Revenue, Gross Margin and Market Share (2016-2017)
2.11 Boehringer Ingelheim
2.11.1 Business Overview
2.11.2 Chronic Obstructive Pulmonary Disease Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Revenue, Gross Margin and Market Share (2016-2017)
3 Global Chronic Obstructive Pulmonary Disease Market Competition, by Players
3.1 Global Chronic Obstructive Pulmonary Disease Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Chronic Obstructive Pulmonary Disease Players Market Share
3.2.2 Top 10 Chronic Obstructive Pulmonary Disease Players Market Share
3.3 Market Competition Trend
4 Global Chronic Obstructive Pulmonary Disease Market Size by Regions
4.1 Global Chronic Obstructive Pulmonary Disease Revenue and Market Share by Regions
4.2 North America Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
4.3 Europe Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
4.5 South America Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
5 North America Chronic Obstructive Pulmonary Disease Revenue by Countries
5.1 North America Chronic Obstructive Pulmonary Disease Revenue by Countries (2013-2018)
5.2 USA Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
5.3 Canada Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
5.4 Mexico Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
6 Europe Chronic Obstructive Pulmonary Disease Revenue by Countries
6.1 Europe Chronic Obstructive Pulmonary Disease Revenue by Countries (2013-2018)
6.2 Germany Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
6.3 UK Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
6.4 France Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
6.5 Russia Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
6.6 Italy Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Chronic Obstructive Pulmonary Disease Revenue by Countries
7.1 Asia-Pacific Chronic Obstructive Pulmonary Disease Revenue by Countries (2013-2018)
7.2 China Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
7.3 Japan Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
7.4 Korea Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
7.5 India Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
8 South America Chronic Obstructive Pulmonary Disease Revenue by Countries
8.1 South America Chronic Obstructive Pulmonary Disease Revenue by Countries (2013-2018)
8.2 Brazil Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
8.3 Argentina Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
8.4 Colombia Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Chronic Obstructive Pulmonary Disease by Countries
9.1 Middle East and Africa Chronic Obstructive Pulmonary Disease Revenue by Countries (2013-2018)
9.2 Saudi Arabia Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
9.3 UAE Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
9.4 Egypt Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
9.5 Nigeria Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
9.6 South Africa Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
10 Global Chronic Obstructive Pulmonary Disease Market Segment by Type
10.1 Global Chronic Obstructive Pulmonary Disease Revenue and Market Share by Type (2013-2018)
10.2 Global Chronic Obstructive Pulmonary Disease Market Forecast by Type (2018-2023)
10.3 Bronchodilators Revenue Growth Rate (2013-2023)
10.4 Glucocorticoids Revenue Growth Rate (2013-2023)
10.5 Other Revenue Growth Rate (2013-2023)
11 Global Chronic Obstructive Pulmonary Disease Market Segment by Application
11.1 Global Chronic Obstructive Pulmonary Disease Revenue Market Share by Application (2013-2018)
11.2 Chronic Obstructive Pulmonary Disease Market Forecast by Application (2018-2023)
11.3 Prevention Revenue Growth (2013-2018)
11.4 Diagnostic Revenue Growth (2013-2018)
11.5 Treatment Revenue Growth (2013-2018)
12 Global Chronic Obstructive Pulmonary Disease Market Size Forecast (2018-2023)
12.1 Global Chronic Obstructive Pulmonary Disease Market Size Forecast (2018-2023)
12.2 Global Chronic Obstructive Pulmonary Disease Market Forecast by Regions (2018-2023)
12.3 North America Chronic Obstructive Pulmonary Disease Revenue Market Forecast (2018-2023)
12.4 Europe Chronic Obstructive Pulmonary Disease Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Chronic Obstructive Pulmonary Disease Revenue Market Forecast (2018-2023)
12.6 South America Chronic Obstructive Pulmonary Disease Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Chronic Obstructive Pulmonary Disease Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
1 Chronic Obstructive Pulmonary Disease Market Overview
1.1 Product Overview and Scope of Chronic Obstructive Pulmonary Disease
1.2 Classification of Chronic Obstructive Pulmonary Disease by Types
1.2.1 Global Chronic Obstructive Pulmonary Disease Revenue Comparison by Types (2017-2023)
1.2.2 Global Chronic Obstructive Pulmonary Disease Revenue Market Share by Types in 2017
1.2.3 Bronchodilators
1.2.4 Glucocorticoids
1.2.5 Other
1.3 Global Chronic Obstructive Pulmonary Disease Market by Application
1.3.1 Global Chronic Obstructive Pulmonary Disease Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Prevention
1.3.3 Diagnostic
1.3.4 Treatment
1.4 Global Chronic Obstructive Pulmonary Disease Market by Regions
1.4.1 Global Chronic Obstructive Pulmonary Disease Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Chronic Obstructive Pulmonary Disease Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Chronic Obstructive Pulmonary Disease Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Chronic Obstructive Pulmonary Disease Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Chronic Obstructive Pulmonary Disease Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Chronic Obstructive Pulmonary Disease Status and Prospect (2013-2023)
1.5 Global Market Size of Chronic Obstructive Pulmonary Disease (2013-2023)
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 Business Overview
2.1.2 Chronic Obstructive Pulmonary Disease Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 AstraZeneca Chronic Obstructive Pulmonary Disease Revenue, Gross Margin and Market Share (2016-2017)
2.2 GSK
2.2.1 Business Overview
2.2.2 Chronic Obstructive Pulmonary Disease Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 GSK Chronic Obstructive Pulmonary Disease Revenue, Gross Margin and Market Share (2016-2017)
2.3 MSD
2.3.1 Business Overview
2.3.2 Chronic Obstructive Pulmonary Disease Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 MSD Chronic Obstructive Pulmonary Disease Revenue, Gross Margin and Market Share (2016-2017)
2.4 Sunovion
2.4.1 Business Overview
2.4.2 Chronic Obstructive Pulmonary Disease Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sunovion Chronic Obstructive Pulmonary Disease Revenue, Gross Margin and Market Share (2016-2017)
2.5 Novartis
2.5.1 Business Overview
2.5.2 Chronic Obstructive Pulmonary Disease Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Novartis Chronic Obstructive Pulmonary Disease Revenue, Gross Margin and Market Share (2016-2017)
2.6 Roche Group
2.6.1 Business Overview
2.6.2 Chronic Obstructive Pulmonary Disease Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Roche Group Chronic Obstructive Pulmonary Disease Revenue, Gross Margin and Market Share (2016-2017)
2.7 Pfizer
2.7.1 Business Overview
2.7.2 Chronic Obstructive Pulmonary Disease Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Pfizer Chronic Obstructive Pulmonary Disease Revenue, Gross Margin and Market Share (2016-2017)
2.8 Jubilant Pharma Limited
2.8.1 Business Overview
2.8.2 Chronic Obstructive Pulmonary Disease Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Jubilant Pharma Limited Chronic Obstructive Pulmonary Disease Revenue, Gross Margin and Market Share (2016-2017)
2.9 Almirall
2.9.1 Business Overview
2.9.2 Chronic Obstructive Pulmonary Disease Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Almirall Chronic Obstructive Pulmonary Disease Revenue, Gross Margin and Market Share (2016-2017)
2.10 Horizon Pharma
2.10.1 Business Overview
2.10.2 Chronic Obstructive Pulmonary Disease Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Horizon Pharma Chronic Obstructive Pulmonary Disease Revenue, Gross Margin and Market Share (2016-2017)
2.11 Boehringer Ingelheim
2.11.1 Business Overview
2.11.2 Chronic Obstructive Pulmonary Disease Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Revenue, Gross Margin and Market Share (2016-2017)
3 Global Chronic Obstructive Pulmonary Disease Market Competition, by Players
3.1 Global Chronic Obstructive Pulmonary Disease Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Chronic Obstructive Pulmonary Disease Players Market Share
3.2.2 Top 10 Chronic Obstructive Pulmonary Disease Players Market Share
3.3 Market Competition Trend
4 Global Chronic Obstructive Pulmonary Disease Market Size by Regions
4.1 Global Chronic Obstructive Pulmonary Disease Revenue and Market Share by Regions
4.2 North America Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
4.3 Europe Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
4.5 South America Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
5 North America Chronic Obstructive Pulmonary Disease Revenue by Countries
5.1 North America Chronic Obstructive Pulmonary Disease Revenue by Countries (2013-2018)
5.2 USA Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
5.3 Canada Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
5.4 Mexico Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
6 Europe Chronic Obstructive Pulmonary Disease Revenue by Countries
6.1 Europe Chronic Obstructive Pulmonary Disease Revenue by Countries (2013-2018)
6.2 Germany Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
6.3 UK Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
6.4 France Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
6.5 Russia Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
6.6 Italy Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Chronic Obstructive Pulmonary Disease Revenue by Countries
7.1 Asia-Pacific Chronic Obstructive Pulmonary Disease Revenue by Countries (2013-2018)
7.2 China Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
7.3 Japan Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
7.4 Korea Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
7.5 India Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
8 South America Chronic Obstructive Pulmonary Disease Revenue by Countries
8.1 South America Chronic Obstructive Pulmonary Disease Revenue by Countries (2013-2018)
8.2 Brazil Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
8.3 Argentina Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
8.4 Colombia Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Chronic Obstructive Pulmonary Disease by Countries
9.1 Middle East and Africa Chronic Obstructive Pulmonary Disease Revenue by Countries (2013-2018)
9.2 Saudi Arabia Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
9.3 UAE Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
9.4 Egypt Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
9.5 Nigeria Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
9.6 South Africa Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
10 Global Chronic Obstructive Pulmonary Disease Market Segment by Type
10.1 Global Chronic Obstructive Pulmonary Disease Revenue and Market Share by Type (2013-2018)
10.2 Global Chronic Obstructive Pulmonary Disease Market Forecast by Type (2018-2023)
10.3 Bronchodilators Revenue Growth Rate (2013-2023)
10.4 Glucocorticoids Revenue Growth Rate (2013-2023)
10.5 Other Revenue Growth Rate (2013-2023)
11 Global Chronic Obstructive Pulmonary Disease Market Segment by Application
11.1 Global Chronic Obstructive Pulmonary Disease Revenue Market Share by Application (2013-2018)
11.2 Chronic Obstructive Pulmonary Disease Market Forecast by Application (2018-2023)
11.3 Prevention Revenue Growth (2013-2018)
11.4 Diagnostic Revenue Growth (2013-2018)
11.5 Treatment Revenue Growth (2013-2018)
12 Global Chronic Obstructive Pulmonary Disease Market Size Forecast (2018-2023)
12.1 Global Chronic Obstructive Pulmonary Disease Market Size Forecast (2018-2023)
12.2 Global Chronic Obstructive Pulmonary Disease Market Forecast by Regions (2018-2023)
12.3 North America Chronic Obstructive Pulmonary Disease Revenue Market Forecast (2018-2023)
12.4 Europe Chronic Obstructive Pulmonary Disease Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Chronic Obstructive Pulmonary Disease Revenue Market Forecast (2018-2023)
12.6 South America Chronic Obstructive Pulmonary Disease Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Chronic Obstructive Pulmonary Disease Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Chronic Obstructive Pulmonary Disease Picture
Table Product Specifications of Chronic Obstructive Pulmonary Disease
Table Global Chronic Obstructive Pulmonary Disease and Revenue (Million USD) Market Split by Product Type
Figure Global Chronic Obstructive Pulmonary Disease Revenue Market Share by Types in 2017
Figure Bronchodilators Picture
Figure Glucocorticoids Picture
Figure Other Picture
Table Global Chronic Obstructive Pulmonary Disease Revenue (Million USD) by Application (2013-2023)
Figure Chronic Obstructive Pulmonary Disease Revenue Market Share by Applications in 2017
Figure Prevention Picture
Figure Diagnostic Picture
Figure Treatment Picture
Table Global Market Chronic Obstructive Pulmonary Disease Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Chronic Obstructive Pulmonary Disease Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Chronic Obstructive Pulmonary Disease Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Chronic Obstructive Pulmonary Disease Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Chronic Obstructive Pulmonary Disease Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Chronic Obstructive Pulmonary Disease Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Chronic Obstructive Pulmonary Disease Revenue (Million USD) and Growth Rate (2013-2023)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Chronic Obstructive Pulmonary Disease Type and Applications
Table AstraZeneca Chronic Obstructive Pulmonary Disease Revenue, Gross Margin and Market Share (2016-2017)
Table GSK Basic Information, Manufacturing Base and Competitors
Table GSK Chronic Obstructive Pulmonary Disease Type and Applications
Table GSK Chronic Obstructive Pulmonary Disease Revenue, Gross Margin and Market Share (2016-2017)
Table MSD Basic Information, Manufacturing Base and Competitors
Table MSD Chronic Obstructive Pulmonary Disease Type and Applications
Table MSD Chronic Obstructive Pulmonary Disease Revenue, Gross Margin and Market Share (2016-2017)
Table Sunovion Basic Information, Manufacturing Base and Competitors
Table Sunovion Chronic Obstructive Pulmonary Disease Type and Applications
Table Sunovion Chronic Obstructive Pulmonary Disease Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Chronic Obstructive Pulmonary Disease Type and Applications
Table Novartis Chronic Obstructive Pulmonary Disease Revenue, Gross Margin and Market Share (2016-2017)
Table Roche Group Basic Information, Manufacturing Base and Competitors
Table Roche Group Chronic Obstructive Pulmonary Disease Type and Applications
Table Roche Group Chronic Obstructive Pulmonary Disease Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Chronic Obstructive Pulmonary Disease Type and Applications
Table Pfizer Chronic Obstructive Pulmonary Disease Revenue, Gross Margin and Market Share (2016-2017)
Table Jubilant Pharma Limited Basic Information, Manufacturing Base and Competitors
Table Jubilant Pharma Limited Chronic Obstructive Pulmonary Disease Type and Applications
Table Jubilant Pharma Limited Chronic Obstructive Pulmonary Disease Revenue, Gross Margin and Market Share (2016-2017)
Table Almirall Basic Information, Manufacturing Base and Competitors
Table Almirall Chronic Obstructive Pulmonary Disease Type and Applications
Table Almirall Chronic Obstructive Pulmonary Disease Revenue, Gross Margin and Market Share (2016-2017)
Table Horizon Pharma Basic Information, Manufacturing Base and Competitors
Table Horizon Pharma Chronic Obstructive Pulmonary Disease Type and Applications
Table Horizon Pharma Chronic Obstructive Pulmonary Disease Revenue, Gross Margin and Market Share (2016-2017)
Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Type and Applications
Table Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Revenue, Gross Margin and Market Share (2016-2017)
Table Global Chronic Obstructive Pulmonary Disease Revenue (Million USD) by Players (2013-2018)
Table Global Chronic Obstructive Pulmonary Disease Revenue Share by Players (2013-2018)
Figure Global Chronic Obstructive Pulmonary Disease Revenue Share by Players in 2016
Figure Global Chronic Obstructive Pulmonary Disease Revenue Share by Players in 2017
Figure Global Top 5 Players Chronic Obstructive Pulmonary Disease Revenue Market Share in 2017
Figure Global Top 10 Players Chronic Obstructive Pulmonary Disease Revenue Market Share in 2017
Figure Global Chronic Obstructive Pulmonary Disease Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Chronic Obstructive Pulmonary Disease Revenue (Million USD) by Regions (2013-2018)
Table Global Chronic Obstructive Pulmonary Disease Revenue Market Share by Regions (2013-2018)
Figure Global Chronic Obstructive Pulmonary Disease Revenue Market Share by Regions (2013-2018)
Figure Global Chronic Obstructive Pulmonary Disease Revenue Market Share by Regions in 2017
Figure North America Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
Figure Europe Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
Figure South America Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
Table North America Chronic Obstructive Pulmonary Disease Revenue by Countries (2013-2018)
Table North America Chronic Obstructive Pulmonary Disease Revenue Market Share by Countries (2013-2018)
Figure North America Chronic Obstructive Pulmonary Disease Revenue Market Share by Countries (2013-2018)
Figure North America Chronic Obstructive Pulmonary Disease Revenue Market Share by Countries in 2017
Figure USA Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
Figure Canada Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
Figure Mexico Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
Table Europe Chronic Obstructive Pulmonary Disease Revenue (Million USD) by Countries (2013-2018)
Figure Europe Chronic Obstructive Pulmonary Disease Revenue Market Share by Countries (2013-2018)
Figure Europe Chronic Obstructive Pulmonary Disease Revenue Market Share by Countries in 2017
Figure Germany Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
Figure UK Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
Figure France Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
Figure Russia Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
Figure Italy Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Chronic Obstructive Pulmonary Disease Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Chronic Obstructive Pulmonary Disease Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Chronic Obstructive Pulmonary Disease Revenue Market Share by Countries in 2017
Figure China Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
Figure Japan Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
Figure Korea Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
Figure India Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
Table South America Chronic Obstructive Pulmonary Disease Revenue by Countries (2013-2018)
Table South America Chronic Obstructive Pulmonary Disease Revenue Market Share by Countries (2013-2018)
Figure South America Chronic Obstructive Pulmonary Disease Revenue Market Share by Countries (2013-2018)
Figure South America Chronic Obstructive Pulmonary Disease Revenue Market Share by Countries in 2017
Figure Brazil Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
Figure Argentina Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
Figure Colombia Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Chronic Obstructive Pulmonary Disease Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Chronic Obstructive Pulmonary Disease Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Chronic Obstructive Pulmonary Disease Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Chronic Obstructive Pulmonary Disease Revenue Market Share by Countries in 2017
Figure Saudi Arabia Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
Figure UAE Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
Figure Egypt Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
Figure Nigeria Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
Figure South Africa Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
Table Global Chronic Obstructive Pulmonary Disease Revenue (Million USD) by Type (2013-2018)
Table Global Chronic Obstructive Pulmonary Disease Revenue Share by Type (2013-2018)
Figure Global Chronic Obstructive Pulmonary Disease Revenue Share by Type (2013-2018)
Figure Global Chronic Obstructive Pulmonary Disease Revenue Share by Type in 2017
Table Global Chronic Obstructive Pulmonary Disease Revenue Forecast by Type (2018-2023)
Figure Global Chronic Obstructive Pulmonary Disease Market Share Forecast by Type (2018-2023)
Figure Global Bronchodilators Revenue Growth Rate (2013-2018)
Figure Global Glucocorticoids Revenue Growth Rate (2013-2018)
Figure Global Other Revenue Growth Rate (2013-2018)
Table Global Chronic Obstructive Pulmonary Disease Revenue by Application (2013-2018)
Table Global Chronic Obstructive Pulmonary Disease Revenue Share by Application (2013-2018)
Figure Global Chronic Obstructive Pulmonary Disease Revenue Share by Application (2013-2018)
Figure Global Chronic Obstructive Pulmonary Disease Revenue Share by Application in 2017
Table Global Chronic Obstructive Pulmonary Disease Revenue Forecast by Application (2018-2023)
Figure Global Chronic Obstructive Pulmonary Disease Market Share Forecast by Application (2018-2023)
Figure Global Prevention Revenue Growth Rate (2013-2018)
Figure Global Diagnostic Revenue Growth Rate (2013-2018)
Figure Global Treatment Revenue Growth Rate (2013-2018)
Figure Global Chronic Obstructive Pulmonary Disease Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Chronic Obstructive Pulmonary Disease Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Chronic Obstructive Pulmonary Disease Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Chronic Obstructive Pulmonary Disease Revenue Market Forecast (2018-2023)
Figure Europe Chronic Obstructive Pulmonary Disease Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Chronic Obstructive Pulmonary Disease Revenue Market Forecast (2018-2023)
Figure South America Chronic Obstructive Pulmonary Disease Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Chronic Obstructive Pulmonary Disease Revenue Market Forecast (2018-2023)
Figure Chronic Obstructive Pulmonary Disease Picture
Table Product Specifications of Chronic Obstructive Pulmonary Disease
Table Global Chronic Obstructive Pulmonary Disease and Revenue (Million USD) Market Split by Product Type
Figure Global Chronic Obstructive Pulmonary Disease Revenue Market Share by Types in 2017
Figure Bronchodilators Picture
Figure Glucocorticoids Picture
Figure Other Picture
Table Global Chronic Obstructive Pulmonary Disease Revenue (Million USD) by Application (2013-2023)
Figure Chronic Obstructive Pulmonary Disease Revenue Market Share by Applications in 2017
Figure Prevention Picture
Figure Diagnostic Picture
Figure Treatment Picture
Table Global Market Chronic Obstructive Pulmonary Disease Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Chronic Obstructive Pulmonary Disease Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Chronic Obstructive Pulmonary Disease Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Chronic Obstructive Pulmonary Disease Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Chronic Obstructive Pulmonary Disease Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Chronic Obstructive Pulmonary Disease Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Chronic Obstructive Pulmonary Disease Revenue (Million USD) and Growth Rate (2013-2023)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Chronic Obstructive Pulmonary Disease Type and Applications
Table AstraZeneca Chronic Obstructive Pulmonary Disease Revenue, Gross Margin and Market Share (2016-2017)
Table GSK Basic Information, Manufacturing Base and Competitors
Table GSK Chronic Obstructive Pulmonary Disease Type and Applications
Table GSK Chronic Obstructive Pulmonary Disease Revenue, Gross Margin and Market Share (2016-2017)
Table MSD Basic Information, Manufacturing Base and Competitors
Table MSD Chronic Obstructive Pulmonary Disease Type and Applications
Table MSD Chronic Obstructive Pulmonary Disease Revenue, Gross Margin and Market Share (2016-2017)
Table Sunovion Basic Information, Manufacturing Base and Competitors
Table Sunovion Chronic Obstructive Pulmonary Disease Type and Applications
Table Sunovion Chronic Obstructive Pulmonary Disease Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Chronic Obstructive Pulmonary Disease Type and Applications
Table Novartis Chronic Obstructive Pulmonary Disease Revenue, Gross Margin and Market Share (2016-2017)
Table Roche Group Basic Information, Manufacturing Base and Competitors
Table Roche Group Chronic Obstructive Pulmonary Disease Type and Applications
Table Roche Group Chronic Obstructive Pulmonary Disease Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Chronic Obstructive Pulmonary Disease Type and Applications
Table Pfizer Chronic Obstructive Pulmonary Disease Revenue, Gross Margin and Market Share (2016-2017)
Table Jubilant Pharma Limited Basic Information, Manufacturing Base and Competitors
Table Jubilant Pharma Limited Chronic Obstructive Pulmonary Disease Type and Applications
Table Jubilant Pharma Limited Chronic Obstructive Pulmonary Disease Revenue, Gross Margin and Market Share (2016-2017)
Table Almirall Basic Information, Manufacturing Base and Competitors
Table Almirall Chronic Obstructive Pulmonary Disease Type and Applications
Table Almirall Chronic Obstructive Pulmonary Disease Revenue, Gross Margin and Market Share (2016-2017)
Table Horizon Pharma Basic Information, Manufacturing Base and Competitors
Table Horizon Pharma Chronic Obstructive Pulmonary Disease Type and Applications
Table Horizon Pharma Chronic Obstructive Pulmonary Disease Revenue, Gross Margin and Market Share (2016-2017)
Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Type and Applications
Table Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Revenue, Gross Margin and Market Share (2016-2017)
Table Global Chronic Obstructive Pulmonary Disease Revenue (Million USD) by Players (2013-2018)
Table Global Chronic Obstructive Pulmonary Disease Revenue Share by Players (2013-2018)
Figure Global Chronic Obstructive Pulmonary Disease Revenue Share by Players in 2016
Figure Global Chronic Obstructive Pulmonary Disease Revenue Share by Players in 2017
Figure Global Top 5 Players Chronic Obstructive Pulmonary Disease Revenue Market Share in 2017
Figure Global Top 10 Players Chronic Obstructive Pulmonary Disease Revenue Market Share in 2017
Figure Global Chronic Obstructive Pulmonary Disease Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Chronic Obstructive Pulmonary Disease Revenue (Million USD) by Regions (2013-2018)
Table Global Chronic Obstructive Pulmonary Disease Revenue Market Share by Regions (2013-2018)
Figure Global Chronic Obstructive Pulmonary Disease Revenue Market Share by Regions (2013-2018)
Figure Global Chronic Obstructive Pulmonary Disease Revenue Market Share by Regions in 2017
Figure North America Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
Figure Europe Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
Figure South America Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
Table North America Chronic Obstructive Pulmonary Disease Revenue by Countries (2013-2018)
Table North America Chronic Obstructive Pulmonary Disease Revenue Market Share by Countries (2013-2018)
Figure North America Chronic Obstructive Pulmonary Disease Revenue Market Share by Countries (2013-2018)
Figure North America Chronic Obstructive Pulmonary Disease Revenue Market Share by Countries in 2017
Figure USA Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
Figure Canada Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
Figure Mexico Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
Table Europe Chronic Obstructive Pulmonary Disease Revenue (Million USD) by Countries (2013-2018)
Figure Europe Chronic Obstructive Pulmonary Disease Revenue Market Share by Countries (2013-2018)
Figure Europe Chronic Obstructive Pulmonary Disease Revenue Market Share by Countries in 2017
Figure Germany Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
Figure UK Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
Figure France Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
Figure Russia Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
Figure Italy Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Chronic Obstructive Pulmonary Disease Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Chronic Obstructive Pulmonary Disease Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Chronic Obstructive Pulmonary Disease Revenue Market Share by Countries in 2017
Figure China Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
Figure Japan Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
Figure Korea Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
Figure India Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
Table South America Chronic Obstructive Pulmonary Disease Revenue by Countries (2013-2018)
Table South America Chronic Obstructive Pulmonary Disease Revenue Market Share by Countries (2013-2018)
Figure South America Chronic Obstructive Pulmonary Disease Revenue Market Share by Countries (2013-2018)
Figure South America Chronic Obstructive Pulmonary Disease Revenue Market Share by Countries in 2017
Figure Brazil Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
Figure Argentina Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
Figure Colombia Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Chronic Obstructive Pulmonary Disease Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Chronic Obstructive Pulmonary Disease Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Chronic Obstructive Pulmonary Disease Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Chronic Obstructive Pulmonary Disease Revenue Market Share by Countries in 2017
Figure Saudi Arabia Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
Figure UAE Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
Figure Egypt Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
Figure Nigeria Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
Figure South Africa Chronic Obstructive Pulmonary Disease Revenue and Growth Rate (2013-2018)
Table Global Chronic Obstructive Pulmonary Disease Revenue (Million USD) by Type (2013-2018)
Table Global Chronic Obstructive Pulmonary Disease Revenue Share by Type (2013-2018)
Figure Global Chronic Obstructive Pulmonary Disease Revenue Share by Type (2013-2018)
Figure Global Chronic Obstructive Pulmonary Disease Revenue Share by Type in 2017
Table Global Chronic Obstructive Pulmonary Disease Revenue Forecast by Type (2018-2023)
Figure Global Chronic Obstructive Pulmonary Disease Market Share Forecast by Type (2018-2023)
Figure Global Bronchodilators Revenue Growth Rate (2013-2018)
Figure Global Glucocorticoids Revenue Growth Rate (2013-2018)
Figure Global Other Revenue Growth Rate (2013-2018)
Table Global Chronic Obstructive Pulmonary Disease Revenue by Application (2013-2018)
Table Global Chronic Obstructive Pulmonary Disease Revenue Share by Application (2013-2018)
Figure Global Chronic Obstructive Pulmonary Disease Revenue Share by Application (2013-2018)
Figure Global Chronic Obstructive Pulmonary Disease Revenue Share by Application in 2017
Table Global Chronic Obstructive Pulmonary Disease Revenue Forecast by Application (2018-2023)
Figure Global Chronic Obstructive Pulmonary Disease Market Share Forecast by Application (2018-2023)
Figure Global Prevention Revenue Growth Rate (2013-2018)
Figure Global Diagnostic Revenue Growth Rate (2013-2018)
Figure Global Treatment Revenue Growth Rate (2013-2018)
Figure Global Chronic Obstructive Pulmonary Disease Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Chronic Obstructive Pulmonary Disease Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Chronic Obstructive Pulmonary Disease Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Chronic Obstructive Pulmonary Disease Revenue Market Forecast (2018-2023)
Figure Europe Chronic Obstructive Pulmonary Disease Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Chronic Obstructive Pulmonary Disease Revenue Market Forecast (2018-2023)
Figure South America Chronic Obstructive Pulmonary Disease Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Chronic Obstructive Pulmonary Disease Revenue Market Forecast (2018-2023)
